Saxenda and potassium: what GLP-1 users should actually know

What did @natalienatalie1987 actually say?

She said she lost "50 pounds in six weeks" on Saxenda (liraglutide), was barely eating, went roughly three weeks without a bowel movement, took multiple laxatives at home without success, and ended up in the hospital. The alarming part: doctors told her potassium was "deathly low" at 2.0 mEq/L, called it "life threatening," and said they were "surprised" she was walking. She was admitted for IV potassium replacement and evaluated for additional findings including something on her lungs and a swollen cervix.

She also describes her diet during this period as one yogurt, a slice of pizza, a lollipop, or a protein shake per day. That is not a diet. That is the caloric intake of someone whose appetite suppression has crossed into dangerous restriction territory.

Does the science back this up?

Yes, and this is genuinely serious. Hypokalemia at 2.0 mEq/L is not a minor lab finding. Normal range is 3.5 to 5.0 mEq/L. Below 2.5 is considered severe and carries real risk of life-threatening cardiac arrhythmias.

GLP-1 receptor agonists like liraglutide suppress appetite significantly, which is the point. But that appetite suppression, combined with vomiting, can rapidly deplete electrolytes. A 2023 review by Wilding et al. in Diabetes, Obesity and Metabolism noted that severe nausea and vomiting on GLP-1 medications can drive meaningful electrolyte disturbances if intake drops too low. The vomiting she describes, her near-zero food intake, and the laxative binge all point to the same problem: her body was hemorrhaging electrolytes with almost nothing coming in to replace them.

The 50-pound-in-six-weeks figure is also a red flag. That is roughly 8 pounds per week, well above what even aggressive GLP-1 therapy would typically produce through fat loss alone. Significant lean mass loss, dehydration, and electrolyte depletion would be required to hit those numbers. That is not a success story. That is a warning sign dressed up as one.

What did they get wrong (or right)?

She got the urgency right: she went to the hospital, and that was the correct call. Credit where it is due.

But she framed 50 pounds in six weeks as a positive outcome, and that framing is wrong. Rapid weight loss at that rate is associated with serious complications including gallstones, muscle wasting, and electrolyte derangement. Johansson et al. (2014, International Journal of Obesity) found that very rapid weight loss significantly increases gallstone risk compared to moderate loss. Her hospitalization is not incidental to her weight loss approach. It is a consequence of it.

She also treated three weeks of no bowel movements as a minor inconvenience to solve with over-the-counter laxatives. Severe constipation on GLP-1 medications is documented, but three weeks without defecation in someone also experiencing vomiting and low oral intake warrants a physician call much earlier, not a home cocktail of Lax-a-Fleet, Smooth Move, MiraLAX, and an enema.

She never mentions telling a prescribing physician any of this was happening. That is a systemic failure worth naming: patients on GLP-1 medications need active clinical monitoring, not just a prescription and a Facebook support group.

What should you actually know?

Hypokalemia is one of the more underappreciated risks when GLP-1-driven appetite suppression goes too far. Your heart needs potassium. At 2.0 mEq/L, the risk of ventricular arrhythmia is real, not theoretical. IV potassium replacement burns, as she accurately described, because infusing it too fast is itself dangerous and must be done slowly.

The warning signs she experienced before hospitalization, including random pains, inability to have a bowel movement for weeks, vomiting, and minimal food intake, are exactly the symptoms that should trigger a call to your prescriber, not a trip to the pharmacy for more laxatives. Adverse effects guidance from the FDA prescribing information for Saxenda specifically notes that patients should be monitored for GI complications and that severe vomiting warrants clinical evaluation.

If you are on any GLP-1 medication and you have not eaten a real meal in days, you are vomiting regularly, or your bowel habits have changed dramatically, that is a clinical conversation, not a TikTok update.